Fitzmaurice P - Search Results

1

Dopamine modulates the plasticity of mechanosensory responses in Caenorhabditis elegans.

Sanyal S, Wintle RF, Kindt KS, Nuttley WM, Arvan R, Fitzmaurice P, Bigras E, Merz DC, Hébert TE, van der Kooy D, Schafer WR, Culotti JG, Van Tol HH. Sanyal S, et al. Among authors: fitzmaurice p. EMBO J. 2004 Jan 28;23(2):473-82. doi: 10.1038/sj.emboj.7600057. Epub 2004 Jan 22. EMBO J. 2004. PMID: 14739932 Free PMC article.

2

Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Tong J, Fitzmaurice PS, Ang LC, Furukawa Y, Guttman M, Kish SJ. Tong J, et al. Ann Neurol. 2004 Jan;55(1):125-9. doi: 10.1002/ana.10814. Ann Neurol. 2004. PMID: 14705122

3

Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.

Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Tong J, et al. Among authors: fitzmaurice p. Neurobiol Dis. 2015 Oct;82:243-253. doi: 10.1016/j.nbd.2015.06.010. Epub 2015 Jun 21. Neurobiol Dis. 2015. PMID: 26102022 Free PMC article.

4

Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.

Fitzmaurice PS, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Fitzmaurice PS, et al. Mov Disord. 2003 Sep;18(9):969-76. doi: 10.1002/mds.10486. Mov Disord. 2003. PMID: 14502663

5

Brain aconitase activity is not decreased in progressive supranuclear palsy.

Fitzmaurice PS, Bamsey CL, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Fitzmaurice PS, et al. Neurology. 2002 Jul 9;59(1):137-8. doi: 10.1212/wnl.59.1.137. Neurology. 2002. PMID: 12105325

6

Why is parkinsonism not a feature of human methamphetamine users?

Moszczynska A, Fitzmaurice P, Ang L, Kalasinsky KS, Schmunk GA, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ. Moszczynska A, et al. Among authors: fitzmaurice p. Brain. 2004 Feb;127(Pt 2):363-70. doi: 10.1093/brain/awh046. Epub 2003 Nov 25. Brain. 2004. PMID: 14645148

7

Is brain gliosis a characteristic of chronic methamphetamine use in the human?

Tong J, Fitzmaurice P, Furukawa Y, Schmunk GA, Wickham DJ, Ang LC, Sherwin A, McCluskey T, Boileau I, Kish SJ. Tong J, et al. Among authors: fitzmaurice p. Neurobiol Dis. 2014 Jul;67:107-18. doi: 10.1016/j.nbd.2014.03.015. Epub 2014 Apr 2. Neurobiol Dis. 2014. PMID: 24704312

8

Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine.

Fitzmaurice PS, Tong J, Yazdanpanah M, Liu PP, Kalasinsky KS, Kish SJ. Fitzmaurice PS, et al. J Pharmacol Exp Ther. 2006 Nov;319(2):703-9. doi: 10.1124/jpet.106.109173. Epub 2006 Jul 20. J Pharmacol Exp Ther. 2006. PMID: 16857724

9

Brain serotonin transporter in human methamphetamine users.

Kish SJ, Fitzmaurice PS, Boileau I, Schmunk GA, Ang LC, Furukawa Y, Chang LJ, Wickham DJ, Sherwin A, Tong J. Kish SJ, et al. Among authors: fitzmaurice ps. Psychopharmacology (Berl). 2009 Mar;202(4):649-61. doi: 10.1007/s00213-008-1346-x. Epub 2008 Oct 8. Psychopharmacology (Berl). 2009. PMID: 18841348

10

Do glutathione levels decline in aging human brain?

Tong J, Fitzmaurice PS, Moszczynska A, Mattina K, Ang LC, Boileau I, Furukawa Y, Sailasuta N, Kish SJ. Tong J, et al. Among authors: fitzmaurice ps. Free Radic Biol Med. 2016 Apr;93:110-7. doi: 10.1016/j.freeradbiomed.2016.01.029. Epub 2016 Feb 1. Free Radic Biol Med. 2016. PMID: 26845616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page